Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Sunshine Biopharma Inc. has filed 405 SEC EDGAR filings since 25 May 2007

SEC filing history

Showing 176-200 of 374 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
22 Feb 2022
Reporting date
18 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
18 Feb 2022
Reporting date
10 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
18 Feb 2022
Reporting date
10 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41282

CURRENT REPORT

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
Next action
Verify source filing
424B4 File 333-259394

424B4

Filing date
17 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259394

EFFECT filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-259394

FORM S-1 AMENDMENT 4

Filing date
14 Feb 2022
Reporting date
Not listed
Next action
Verify source filing
CERT File 001-41282

8A CERT

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41282

CURRENT REPORT

Filing date
10 Feb 2022
Reporting date
09 Feb 2022
Next action
Verify source filing
8-A12B File 001-41282

FORM 8-A12B

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-259394

FORM S-1 AMENDMENT 3

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
08 Feb 2022
Reporting date
07 Feb 2022
Next action
Verify source filing
S-1/A File 333-259394

FORM S-1 AMENDMENT 2

Filing date
03 Feb 2022
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-259394

AMENDMENT TO FORM S-1

Filing date
24 Jan 2022
Reporting date
Not listed
Next action
Verify source filing
DEF 14C File 000-52898

DEF 14C

Filing date
18 Jan 2022
Reporting date
20 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-52898

PRE 14C filing

Filing date
06 Jan 2022
Reporting date
15 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
22 Dec 2021
Reporting date
20 Dec 2021
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
16 Dec 2021
Reporting date
31 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
14 Dec 2021
Reporting date
31 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
09 Dec 2021
Reporting date
31 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52898

CURRENT REPORT

Filing date
03 Nov 2021
Reporting date
31 Oct 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .